Department of Molecular and Medical Virology, Ruhr-University Bochum, 44801 Bochum, Germany.
Viruses. 2021 Apr 28;13(5):792. doi: 10.3390/v13050792.
SARS-CoV-2 has spread across the globe with an astonishing velocity and lethality that has put scientist and pharmaceutical companies worldwide on the spot to develop novel treatment options and reliable vaccination for billions of people. To combat its associated disease COVID-19 and potentially newly emerging coronaviruses, numerous pre-clinical cell culture techniques have progressively been used, which allow the study of SARS-CoV-2 pathogenesis, basic replication mechanisms, and drug efficiency in the most authentic context. Hence, this review was designed to summarize and discuss currently used in vitro and ex vivo cell culture systems and will illustrate how these systems will help us to face the challenges imposed by the current SARS-CoV-2 pandemic.
SARS-CoV-2 以惊人的速度和致命性在全球范围内传播,这使得世界各地的科学家和制药公司都在努力开发针对数十亿人的新型治疗方案和可靠疫苗。为了对抗其相关疾病 COVID-19 和潜在的新出现的冠状病毒,已经逐步使用了许多临床前细胞培养技术,这些技术允许在最真实的背景下研究 SARS-CoV-2 的发病机制、基本复制机制和药物功效。因此,本综述旨在总结和讨论目前使用的体外和离体细胞培养系统,并说明这些系统将如何帮助我们应对当前 SARS-CoV-2 大流行带来的挑战。